Glucose and diabetic vascular disease
- PMID: 1644256
- DOI: 10.1096/fasebj.6.11.1644256
Glucose and diabetic vascular disease
Erratum in
- FASEB J 1993 Jan;7(1):237
Abstract
The central therapeutic problem in diabetes mellitus is prevention and treatment of the chronic vascular disease associated with this disorder. Prolonged exposure to hyperglycemia is the primary factor associated with the development of diabetes-specific microvascular disease, and the relationship between deranged glucose metabolism and arterial disease is complicated by many other factors that influence atherogenesis in nondiabetics. Until relatively recently, knowledge about diabetic vascular disease was limited mainly to clinical description. New information about abnormal vascular physiology, ultrastructure, biochemistry, cell biology, and molecular biology now makes it possible to understand in an integrated fashion the major specific mechanisms by which hyperglycemia damages diabetic vessels. Continued progress in this area will further optimize the development of safe and effective drugs for the treatment of diabetic vascular disease.
Similar articles
-
Hyperglycemia and microangiopathy. Direct regulation by glucose of microvascular cells.Lab Invest. 1992 Oct;67(4):416-26. Lab Invest. 1992. PMID: 1434526 Review. No abstract available.
-
The role of protein kinase C activation and the vascular complications of diabetes.Pharmacol Res. 2007 Jun;55(6):498-510. doi: 10.1016/j.phrs.2007.04.016. Epub 2007 May 5. Pharmacol Res. 2007. PMID: 17574431 Review.
-
Biochemistry and molecular cell biology of diabetic complications.Nature. 2001 Dec 13;414(6865):813-20. doi: 10.1038/414813a. Nature. 2001. PMID: 11742414
-
Biochemical and molecular mechanisms in the development of diabetic vascular complications.Diabetes. 1996 Jul;45 Suppl 3:S105-8. doi: 10.2337/diab.45.3.s105. Diabetes. 1996. PMID: 8674872 Review.
-
The cellular and molecular mechanisms of diabetic complications.Endocrinol Metab Clin North Am. 1996 Jun;25(2):255-70. doi: 10.1016/s0889-8529(05)70324-8. Endocrinol Metab Clin North Am. 1996. PMID: 8799700 Review.
Cited by
-
Differential Rates of Glycation Following Exposure to Unique Monosaccharides.Int J Mol Sci. 2024 Jun 25;25(13):6921. doi: 10.3390/ijms25136921. Int J Mol Sci. 2024. PMID: 39000037 Free PMC article.
-
Altered Expression of NF- κ B and SP1 after Exposure to Advanced Glycation End-Products and Effects of Neurotrophic Factors in AGEs Exposed Rat Retinas.J Diabetes Res. 2015;2015:543818. doi: 10.1155/2015/543818. Epub 2015 May 20. J Diabetes Res. 2015. PMID: 26078979 Free PMC article.
-
Diabetes reduces the cholesterol exporter ABCA1 in mouse macrophages and kidneys.J Lipid Res. 2010 Jul;51(7):1719-28. doi: 10.1194/jlr.M003525. Epub 2009 Nov 23. J Lipid Res. 2010. PMID: 19965614 Free PMC article.
-
Role of poly(ADP-ribose) polymerase-1 activation in the pathogenesis of diabetic complications: endothelial dysfunction, as a common underlying theme.Antioxid Redox Signal. 2005 Nov-Dec;7(11-12):1568-80. doi: 10.1089/ars.2005.7.1568. Antioxid Redox Signal. 2005. PMID: 16356120 Free PMC article. Review.
-
Inhibition of advanced glycation end products by red grape skin extract and its antioxidant activity.BMC Complement Altern Med. 2013 Jul 12;13:171. doi: 10.1186/1472-6882-13-171. BMC Complement Altern Med. 2013. PMID: 23849496 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical